12 Psychiatry Headlines You Missed in July 2025

July 2025 brought important developments in psychiatry, from US Food and Drug Administration (FDA) breakthroughs and pivotal depression trials to fresh insights on healthy habits and mental health. This psychiatry month in review also highlights key interviews from the 2025 Southern California Psychiatry Conference (SoCal Psych), including expert perspectives on postpartum depression, tardive dyskinesia, bipolar disorder, and new treatments, such as muscarinic agents for schizophrenia.